Cis-dichlorodiammineplatinum (II), (cis-DDP), is an antineoplastic agent used either alone and more recently in combination with other drugs for the treatment of a variety of malignancies, including testicular, ovarian, lung, bladder and head and neck tumours. In vitro studies with both normal and tumour cell lines suggested that cis-DDP acts as a modifier of radiosensitivity (Richmond et al., 1977; Douple & Richmond, 1980; Murthy et al., 1979; Dritschilo et al., 1979) . Several studies with animal tumours also revealed enhancement of the radiation response when cis-DDP and irradiation were given at short time intervals (Douple & Richmond, 1982; Overgaard et al., 1981; Kyriazis et al., 1983; H6glmeier et al., 1985; Lelieveld et al., 1985) .
An increasing number of clinical phase I-II studies has been carried out with combined treatments of radiotherapy and cis-DDP at varying dose schedules (Reimer et al., 1981; Keizer et al., 1984; Dewit et al., 1985; Pinedo et al., 1983) . However, these data do not allow any firm conclusions as to the effect of cis-DDP in combination with radiotherapy on human normal tissues.
Attention has been drawn to increased acute normal tissue reactions due to the combined use of cancer chemotherapeutic agents with radiotherapy (Phillips et al., 1976; Peckham et al., 1981) . Since the normal tissue tolerance is the limiting factor in the treatment of most malignancies, qualitative and quantitative knowledge of the possible interactions between cis-DDP and radiotherapy on normal tissues is necessary. In addition, information on the optimal dose and timing of cis-DDP in relation to irradiation is needed. The present study reports on the effect of cis-DDP on the radiosensitivity as well as on repair of sublethal radiation damage and repopulation during fractionated radiotherapy in the lip mucosa of mice. This tissue was selected as a model for fast proliferating tissues .
Methods and materials
The experiments were carried out using 8 to 9 weeks old female Naval Medical Research Institute (NMR1) mice. These outbred mice were bred in specific pathogen free conditions and were transported to a conventional housing facility for treatment and follow-up. They were housed 6 per cage with free access to food and water.
Irradiations were delivered with a 60Co gammaray unit. The dose rate at a focus-to-skin distance of 60cm was 170cGymin-1 in some experiments and 140cGymin-1 for others. With the use of a semiclosed Ethraneg (Abbott, Belgium) anaesthesia system (Ang et al., 1982) , 24 mice placed in a supine position could be treated simultaneously. The snouts of the mice were irradiated, while the remaining part of the body was shielded with 7cm thick MCP alloy (Mining Chemical Product; m.p. 70°C) (Xu et al., 1984) .
The solutions of cis-DDP (Platinol®;; kindly provided by 'Bristol, Belgium') were prepared with sterile 0.9% saline shortly before i.p. injections. The drug was always administered in a volume of 0.25 ml per mouse. Drug toxicity was assessed using escalating doses to groups of at least 8 mice, using weight loss and lethality as parameters. In the combined modality treatments several doses of cis-DDP were tested. These drug doses, ranging from 6 to 13 mg kg-1, did not result in any macroscopic change of the mouse lip mucosa. In order to exclude diurnal variations in toxicity, the experiments were always carried out between 4 and 6 p.m.
Experiments with irradiation alone were done in parallel with every combined treatment regimen. To assess the reproducibility, experiments were always repeated once or twice, with an interexperimental variability of about 5% at the isoeffect level (mean peak reaction). Acute lip mucosal reactions were scored 5-6 times per week by at least two observers during the period of 17 to 21 days following the initial irradiation treatment using a semi-quantitative scale (Xu et al., 1984 ). The mean peak reaction level (mean score for a group of mice) for each radiation dose point was used for constructing dose-response curves. Since cis-DDP administration altered the extent of oedema, the influence of this factor on the lip mucosal score was estimated by separately assessing the reaction including or excluding oedema from the calculations of average responses on several occasions. For the various treatment schedules, comparison between the reactions after irradiation alone and after irradiation combined with cis-DDP was also done based on the percentage of animals showing focal desquamation of the mouse lip mucosa. When the animals showed exudative reactions and/or crusting covering more than half of the lips, they were killed. During the period of scoring, mice were also weighed daily in order to assess the toxicity of the combined treatment. The mice were killed when the critical level of 35% weight loss was reached because previous experiments had demonstrated that in such circumstances lethality always followed.
Results
Toxicity of cis-DDP alone and combined with irradiation A series of experiments were carried out to assess toxicity of cis-DDP in the female NMRI mice following single and repeated i.p. injections. For single injection the drug dose needed to induce 50% lethality within a period of 30 days (LD50/30) was found to be 21 mg kg-I in one experiment but later however, the LD50/30 was only 15 to 16mg kg-1.
When 5 i.p. injections of cis-DDP were given at 24 h-intervals, the LD50/30 was estimated to be -21 mg kg-I total dose. The latter result was obtained at the same time period during which the first single injection study was carried out. In both schedules of drug administration, the maximum cis-DDP dose causing no lethality was 13-14mg kg-1.
During the 30 days of observation, the body weight of all animals was recorded daily. The results showed no weight loss for a single injection of 6mgkg-1 drug and -12% loss of body weight following a single treatment of 8mgkg-1 cis-DDP. Weight loss after 10 and 13mgkg-1 single injections varied from 10 to 25% with relatively large individual variations between the mice. Slightly smaller changes in body weight were observed with the repeated daily injections when comparing the same total drug doses up to 10mgkg-'. Following the decrease in body weight, the surviving mice however recovered to more than the initial weight within the observation period. Acute morbidity occurred between 5 and 9 days after drug injection and was always preceded by severe dehydration and dramatic loss of body weight. Macroscopically, the intestines were often swollen with a watery content. Histological preparations of the small intestine, resected immediately post-mortem, showed atrophied crypts and shortened villi.
Combining cis-DDP with irradiation, at any of the doses used, led in a number of experiments to a more pronounced loss of body weight than expected from the sum of weight loss of both agents alone (Table I ). The decrease was observed at the time period of the maximal lip mucosal reaction and persisted for several days. The phenomenon of a greater reduction in body weight was more obvious in fractionated compared with single treatments.
Combined cis-DDP and irradiation: lip mucosal reactions Figure 1 shows the results of two time-line experiments combining 8mg kg-(A) or 13mg kg-1 (B) single i.p. cis-DDP injections with a single radiation dose of 15 Gy.
The drug administered at either 24 h, 6 h, 2 h, 15 min before or 15min, 2h, 6h, 24h, 72h after the irradiation.
No enhancement of the lip mucosal reactions was recorded at any of the time-intervals used. In fact, IRRADIATION AND CIS-DDP ON MOUSE LIP MUCOSA Figure 1 shows that slightly less lip mucosal reactions occurred after the concomitant use of cis-DDP and irradiation. However, this does not necessarily implicate a protective effect and most probably was the result of the often occurring dehydration of the cis-DDP treated animals leading to a reduced oedema score. This would obviously cause an underestimate of the total score relating to the acute lip mucosal reactions; the erythema and desquamation scores were not significantly altered.
In Figure 2 (A and B) , the dose-response curves obtained after single irradiation alone and after i.p. injection of 13mg kg-1 cis-DDP 2 h prior to single irradiation doses, confirm the above mentioned findings. The reduction in the reaction score following combined treatment (Figure 2A) is not significant when the scores for oedema are excluded ( Figure 2B ). Also the percentage of animals showing focal desquamation of the mouse lip mucosa were similar for both treatment modalities (Table II) .
Results of the investigation of a possible influence of cis-DDP on the extent of repair of sublethal radiation damage are presented in Figure 3 . Fractionated, daily treatment of irradiation and cis-DDP (1.2 or 1.6mgkg71 given 30min before each irradiation) for 5 consecutive days resulted in less radiation damage compared with irradiation alone (Figure 3A) , even when the oedema scores were not used for calculating the mean peak reactions ( Figure 3B ). Reduced reactions were not only observed at the day of peak reactions but were found over the whole reaction course after the combined treatment. The lower incidence of spotted desquamation in the mouse lip following the concomitant use of cis-DDP and irradiation is demonstrated in Table II. Experiments combining cis-DDP and two radiation doses given with increasing fractionation intervals (1 to 4h) were done to assess the possible influence of cis-DDP on the rate of repair of sublethal radiation damage. The results did not Figure 4 presents data obtained following the use of 2 equal sized radiation doses separated by 10 days. It was previously shown that this time interval allowed for a large amount of tissue regeneration . In order to assess the effect of cis-DDP on repopulation, 5 daily drug injections were given during the interval between both fractions using either 1.2mg kg-1 or 1.6 mg kg-1 cis-DDP to total doses of 6 mg kg-1 or 8 mg kg-1 respectively. The injections were given daily starting at day 3 after the first irradiation. The reaction curves (total radiation dose of 19 Gy) shown in this figure demonstrate clearly that the addition of repeated drug injections did not alter the course of radiation responses. Similar results were also obtained for the lower radiation doses used.
Discussion
Toxicity Our histological findings are in agreement with the marked intestinal cytotoxicity described earlier in rats and mice (Choie et al., 1981; Kovacs et al., 1982; Luk et al., 1979; Schaeppi et al., 1973) . Obviously, the rapidly developing acute renal damage with cis-DDP doses of more than 6mgkg-1 (Stewart et al., 1986 ) will add to the observed body weight loss and eventual lethality.
The results from our cis-DDP toxicity studies with the NMRI mice showed LD50/30 variations for single i.p. injections. It was also noticed that the responses to the drug were subject to individual variations within one dose group. This is true for every group of mice receiving the same amount of cis-DDP. Investigations on kidney function in mice after cis-DDP administration showed a similarly broad range of individual acute responses at doses above 6mg kg 1 (Stewart et al., 1986) . When the drug was combined with irradiation a more pronounced body weight loss occurred, also at the lowest radiation and drug doses used. This increased toxicity following the combined irradiation and cis-DDP treatment, as compared to the sum of both agents alone, was also reported by others (F. Stewart & L. Dewit, personal communication) and was found previously with other drugs, i.e. actinomycin D (Landuyt et al., 1985) and methotrexate (von der Maase, 1984) . This is probably the result of a spatial combination of normal tissue toxicity, an assumption based on the fact that evidence for systemic toxicity and lip mucosal injury showed a similar onset in time.
Combined cis-DDP and irradiation: lip mucosal reactions The results of our time-line experiments, in which a single injection of cis-DDP was given at various time intervals from I day before to 3 days after a single radiation exposure, showed no clear modifications of the radiation induced lip mucosal damage. Neither was there any evidence of modified radiation damage when a fixed amount of drug was delivered before or after a range of radiation doses. It was also demonstrated that the reduced scores, due to the administration of cis-DDP and occurring in some combined schedules, were probably the result of dehydration of the animals. Since this phenomenon leads to a reduced swelling of the lips, omission of the oedema score shows that only minor differences existed between both combined treatment and radiotherapy alone. The incidence of spotted desquamation in the mouse lip after radiation treatment was not modified with the use of cis-DDP. These results therefore illustrate that the radiosensitivity of this rapidly proliferating tissue does not seem to be affected by cis-DDP for both the time intervals and sequences used.
In agreement with this finding, absence of interaction between radiation and cis-DDP on the skin of mouse foot has been previously reported (Overgaard et al., 1981; Lelieveld et al., 1985) . Some investigators, however, did show a moderate increase of skin reactions in mouse foot (von der Maase, 1984b) as well as in the rat foot (Douple et al., 1979) . A phase I/II clinical study combining radiotherapy and daily low dose cis-DDP for treatment of locally advanced cancers showed no clear increase of the oral mucosal reactions or skin lesions (Keizer et al., 1984) . Other clinical data also indicated no change of radiation induced acute skin reactions when cis-DDP was given concurrently with radiotherapy for treatment of solid tumours (Dewit et al., 1985a; Reimer et al., 1981) . In contrast, a number of studies showed enhancement of radiation damage in the intestinal mucosa of mice when cis-DDP was given i.p. at various time periods before or after single radiation exposure (Luk et al., 1979) ; von der Maase, 1984a). However, the effect only occurred when the drug dose exceeded 6 mg kg-1. An enhancement of acute radiation damage to the small intestine in patients has also been shown to be cis-DDP dose dependent (Dewit et al., 1985a) .
No interaction of cis-DDP with the extent nor the kinetics of repair of sublethal radiation damage was demonstrated in the present study. It was actually found that, following a combined treatment of 5 daily cis-DDP injections given 30min before 5 daily irradiations, the lip mucosal reactions were consistently lower compared with those after radiotherapy alone. This small but significant protective effect could not be explained by dehydration since exclusion of the oedema scores from the calculation of mean peak level of mucosal reaction did not eliminate this phenomenon. These effects may be explained partly by synchronisation occurring during the treatment course. These results on mouse lip mucosa are in agreement with the data of Bartelink et al. (1983) and Lelieveld et al. (1985) on mouse skin, demonstrating no modification of the capability to repair sublethal radiation damage. While inhibition of repair of sublethal radiation damage by cis-DDP has been suggested in several investigations on mouse intestinal epithelium (Dewit et al., 1985b , Bartelink et al., 1983 Burholt et al., 1979) , no such effect was measured when low dose rate irradiation was combined with continuous i.p. infusion of cis-DDP using the same biological model (Fu et al., 1984) .
Finally, the possible interference of cis-DDP with repopulation during fractionated irradiation was also investigated. Our data do not show any influence of fractionated drug treatments (6 or 8mgkg-1 total dose) on the repopulation capacity of mouse lip mucosa. Figure 4 illustrates the results obtained with a total radiatron dose of 29Gy, but similar results were obtained for lower radiation doses. Higher cis-DDP doses could not be tested, since in this combined treatment they always resulted in very severe toxicity and subsequent lethality.
In conclusion, these data on lip mucosa do not show an increase of the radiosensitivity nor an inhibition of repair at the cellular or tissue level. On the contrary, they indicate a minor protection (6-9%) dependent on the fractionation schedule used. Thus it follows from our results and from data in the literature that the effect of cis-DDP on radiation treatment is strongly dependent on the type of tissue involved. It also seems clear that large combined effects are apparent in intestinal mucosa when high drug doses are used. This could be related to the fact that at these doses of cis-DDP a marked independent cell killing in gut mucosa occurs from the drug alone.
There certainly remains a need for more data derived from the combination of fractionated drug and radiation treatments used concomitantly as well as alternately in a variety of normal and tumour tissues, to define the optimal use of combined modalities in clinical practice.
